Centene's Medicare and Commercial Windfalls Drive Annual Guidance Increase
Dow Jones07-28 18:28
Centene raised its 2026 adjusted diluted EPS guidance floor to greater than $4.80, up from earlier expectations. The company said the increase reflects approximately $0.50 per share of non-recurring items in the Medicare and Commercial segments. In Medicare, the company cited favorable resolution of programmatic elements for the 2025 benefit year. The guidance update also reflects higher revenue expectations, with total revenue guidance lifted by $6 billion to a range of $193.5 billion to $197.5 billion, driven by premium tax revenue, Marketplace, and Medicaid.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments